In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines (Q44559237)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 August 2003
edit
Language Label Description Also known as
English
In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines
scientific article published on 21 August 2003

    Statements

    In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines (English)
    Kara Johnson
    Amie S Corbin
    Eric P Stoffregen
    Stephanie Willis
    Michael M Mauro
    Junia V Melo
    Michael W Deininger
    21 August 2003
    208-215

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit